151 related articles for article (PubMed ID: 15573295)
1. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
Rathsmann P; Jacobs GF; Müller RD
Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
[TBL] [Abstract][Full Text] [Related]
2. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
Wiklund LM; Brolin I; Sjöholm K
Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of iopentol and iohexol after intravenous injection.
Jakobsen JA; Kolbenstvedt AN; Berg KJ
Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profiles after nonionic dimeric contrast medium injection.
Böhm I; Speck U; Schild H
Invest Radiol; 2003 Dec; 38(12):776-83. PubMed ID: 14627895
[TBL] [Abstract][Full Text] [Related]
6. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report.
Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K
Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303
[TBL] [Abstract][Full Text] [Related]
8. [Non-ionic iodinated dimeric versus monomeric X-ray contrast media: effects on complement factors in vivo].
Böhm I; Speck U; Schild H
Rofo; 2006 Mar; 178(3):306-12. PubMed ID: 16508838
[TBL] [Abstract][Full Text] [Related]
9. Delayed adverse reactions to iodinated contrast media and their risk factors.
Hosoya T; Yamaguchi K; Akutsu T; Mitsuhashi Y; Kondo S; Sugai Y; Adachi M
Radiat Med; 2000; 18(1):39-45. PubMed ID: 10852654
[TBL] [Abstract][Full Text] [Related]
10. [Delayed adverse reactions following the intravascular administration of a nonionic x-ray contrast medium].
Beyer-Enke SA; Zeitler E; Schneider R
Radiologe; 1992 Apr; 32(4):165-9. PubMed ID: 1598412
[TBL] [Abstract][Full Text] [Related]
11. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
Ng CS; Shaw AD; Bell CS; Samuels JA
AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of contrast media: experimental results in dog and man with CT implications.
Gardeur D; Lautrou J; Millard JC; Berger N; Metzger J
J Comput Assist Tomogr; 1980 Apr; 4(2):178-85. PubMed ID: 7365016
[TBL] [Abstract][Full Text] [Related]
13. Acute and late adverse reactions to low-osmolal contrast media.
Mikkonen R; Kontkanen T; Kivisaari L
Acta Radiol; 1995 Jan; 36(1):72-6. PubMed ID: 7833173
[TBL] [Abstract][Full Text] [Related]
14. A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients.
Sayegh N; Porée C; Baraton J; Skinningsrud K; Nantois C; Lallemand D
Eur Radiol; 1996; 6(4):574-7. PubMed ID: 8798046
[TBL] [Abstract][Full Text] [Related]
15. [Asymptomatic blood pressure and pulse rate changes during intravenous urography. Ionic contrast media vs. nonionic contrast media].
Miwa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Sep; 50(9):1082-6. PubMed ID: 2247349
[TBL] [Abstract][Full Text] [Related]
16. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
17. Peripheral intravenous power injection of iodinated contrast media through 22G and 20G cannulas: can high flow rates be achieved safely? A clinical feasibility study.
Schwab SA; Uder M; Anders K; Heinrich MC; Kuefner MA
Rofo; 2009 Apr; 181(4):355-61. PubMed ID: 19280548
[TBL] [Abstract][Full Text] [Related]
18. Nephropathy in critically Ill patients without preexisting renal disease.
Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R
Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679
[TBL] [Abstract][Full Text] [Related]
19. Intravenous contrast media: use and associated mortality.
Cashman JD; McCredie J; Henry DA
Med J Aust; 1991 Nov; 155(9):618-23. PubMed ID: 1943961
[TBL] [Abstract][Full Text] [Related]
20. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S
In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
